VEGF-A’s function as a potentially therapeutic agent in the treatment of PD is supported by studies that suggest VEGF-A’s involvement in enhancement of DA neuron survival by both direct and indirect mechanisms [71,72]. Here, VEGFA is linked to Parkinson disease.